Evidence map›Paper›PMID 36628294›Full record

ArticleAmerican journal of cancer research2022

Erratum: Downregulation of circ-TRPS1 suppressed prostatic cancer prognoses by regulating miR-124-3p/EZH2 axis-mediated stemness.

Jianjun Sha, Lei Xia, Qing Han, Chenfei Chi, Yinjie Zhu, Jiahua Pan, Yiran Huang, Weiliang Xia, Baijun Dong, Wei Xue and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC
In one paragraph

Article in American journal of cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jianjun ShaDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Lei XiaDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Qing HanSchool of Biomedical Engineering, Shanghai Jiaotong University Shanghai 200240, China.
Chenfei ChiDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Yinjie ZhuDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Jiahua PanDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Yiran HuangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Weiliang XiaSchool of Biomedical Engineering, Shanghai Jiaotong University Shanghai 200240, China.
Baijun DongDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Wei XueDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 200127, China.
Chen YangFudan Institute of Urology, Huashan Hospital, Fudan University Shanghai 200040, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 4372 in vol. 10, PMID: 33415005.].

Identifiers

PMID36628294
PMCPMC9827097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.